All Posts By

Smartkarma Daily Briefs

Daily Brief Equity Bottom-Up: Taiwan Dual-Listings Monitor: TSMC Premium Rangebound; UMC Hits Upper End of Range and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Taiwan Dual-Listings Monitor: TSMC Premium Rangebound; UMC Hits Upper End of Range
  • China Healthcare Weekly (Jun.30) – TCM Companies Witness Soaring Costs, Rising Stars in ADC, 1515.HK
  • Selamat Sempurna (SMSM IJ) – Filter Champion
  • India Channel Insight | Bandhan Bank (BANDHAN IN) | The Other Shoe to Drop
  • Nuvama: Continues to Deliver Strong
  • PC Monitor: Growth Expectations Have Increased Recently; HPE Signals Enterprise AI Acceleration
  • China Consumption Weekly (1 Jul 2024): Douyin, Green Tea, Alibaba, Tencent, Haidilao
  • Perfect Medical (1830 HK): Resilient FY24 And 12.5% Trailing Dividend Yield
  • Delfi Ltd (DELFI.SI) – Friday, Mar 29, 2024
  • Another Debt Downgrade


Taiwan Dual-Listings Monitor: TSMC Premium Rangebound; UMC Hits Upper End of Range

By Vincent Fernando, CFA

  • TSMC: +16.7% Premium, Has Remained Rangebound; Watching for Over 20% or Under 15%
  • UMC: +2% Premium, Upper End of Trading Range, Can Consider Shorting
  • ASE: +9.9% Premium; Spread Could Have Further Room to Bounce Higher

China Healthcare Weekly (Jun.30) – TCM Companies Witness Soaring Costs, Rising Stars in ADC, 1515.HK

By Xinyao (Criss) Wang

  • Investors should be aware of the increasing prices of TCM raw materials, which could lead to fluctuations in profit margins of TCM companies. Investors should prepare for these potential impacts.
  • After years of “fast-follow”, we’ve finally seen products from Chinese pharmaceutical companies stand at the center of the stage for the first time in the new generation of ADC.
  • China Resources Medical’s profitability outlook is not promising due to issues within the Chinese healthcare system. The bottom line is P/B above 1 and P/E above 10x.

Selamat Sempurna (SMSM IJ) – Filter Champion

By Angus Mackintosh

  • Selamat Sempurna is one of the most interesting industrial companies in Indonesia, with a leading market share in filters for auto and heavy equipment markets in Indonesia and overseas.
  • 1Q2024 was impacted by a seasonal slowdow ahead of Lebaran and a decline in sales to Russia, offset by strong US sales. Management remains confident in the outlook for FY2024.
  • Selamat Sempurna will continue to benefit from growth in the filter replacement market for both auto and heavy equipment markets and already has exposure to EVs. Valuations are attractive. 

India Channel Insight | Bandhan Bank (BANDHAN IN) | The Other Shoe to Drop

By Pranav Bhavsar

  • While the street is getting excited about Bandhan Bank (assuming a change in management, end of a bad asset cycle, and lower valuations), we are not.
  • We believe the next set of problems for the bank are yet to be unleashed, and a change in management will only intensify the challenges ahead.
  • We believe the worst is yet to come for the bank. 

Nuvama: Continues to Deliver Strong

By Ankit Agrawal, CFA

  • Nuvama Wealth Management (“Nuvama”)  continues to report strong growth with Q4FY24 revenue at INR 596cr, a growth of 35% YoY. Q4FY24 PAT grew 57% YoY to reach INR 181cr. 
  • Overall, FY24 revenue and PAT ended strong at INR 2063cr (YoY growth of 31%) and INR 597cr (YoY growth of 62%), respectively.
  • FY24 growth was led by the capital markets (revenue grew 64% YoY) segment, aided by favorable cycle and market-share gains. Wealth and asset management segments are also scaling up well.

PC Monitor: Growth Expectations Have Increased Recently; HPE Signals Enterprise AI Acceleration

By Vincent Fernando, CFA

  • PC & Server solutions names have fallen moderately from highs in June, however enterprise server company HPE soared 20% on AI strength.
  • Despite the market pullback from highs, we note that 2025E forward growth expectations have generally increased for the universe over the last month.
  • Latest Taiwan PC company revenues indicate healthy growth and HPE’s management guided for Enterprise AI orders to accelerate.

China Consumption Weekly (1 Jul 2024): Douyin, Green Tea, Alibaba, Tencent, Haidilao

By Ming Lu

  • Douyin’ GMV increased by 300% YoY in the “June 18” sales season.
  • The revenue of a pre-IPO restaurant chain, Green Tea, increased by 55% in 2023.
  • Alibaba’s supermarket chain, Freshippo, opened 12 new stores in June.

Perfect Medical (1830 HK): Resilient FY24 And 12.5% Trailing Dividend Yield

By Sameer Taneja

  • Perfect Medical Health (1830 HK) reported flat revenue/profit growth for FY24 due to a weak Q4 that plagued the entire HK consumer space. H2FY24  revenue/profit growth was -6.3%/-12.5%
  • The company paid a generous dividend of 31.5 cents for FY24 (vs. 30.0 cents), resulting in a 12.5% dividend yield.
  • We will follow up with more details after the earnings call and presentation. 

Delfi Ltd (DELFI.SI) – Friday, Mar 29, 2024

By Value Investors Club

Key points

  • Delfi, the leading chocolate company in Indonesia, is experiencing challenges due to rising cocoa prices
  • Despite a decrease in share price, analysts remain optimistic about Delfi’s future prospects
  • The company’s management team is implementing strategic measures to protect profit margins and improve financial performance, with initiatives planned for 2024 expected to mitigate the impact of cocoa price increases

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Another Debt Downgrade

By Jesus Rodriguez Aguilar

  • Moody’s Ratings downgraded Grifols’ corporate family rating to B3 from B2, with a stable outlook, due to high leverage, and complex, opaque corporate governance involving related-party transactions.
  • Moody’s considers Grifols’s liquidity to still be “fragile,” noting that “while adequate for the next 12 months, beyond that, maintaining adequate liquidity will depend on returning to positive FCF generation.
  • For risk-tolerant investors, the current low share price could present a long-term buying opportunity if Grifols successfully executes its strategic initiatives.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: TIP Taiwan Technology Dividend Highlight Index Rebalance: 12 Changes & US$4bn Round-Trip Trade and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • TIP Taiwan Technology Dividend Highlight Index Rebalance: 12 Changes & US$4bn Round-Trip Trade
  • Merger Arb Mondays (01 Jul) – Henlius, China TCM, GA Pack, CPMC, Asia Cement, Great Eastern
  • (Mostly) Asia M&A, June 2024: Fancl, Capitol Health, Infocom,Jeisys Medical, Nagatanien, Henlius Bio
  • Potential Recurrence of Local Flow Trade Patterns in Hyundai Glovis’s Stock Dividend Event
  • EQD / NSE Vol Update / IVs Rise in Conjunction with Equities Counter to Regular Spot-Vol Correlation


TIP Taiwan Technology Dividend Highlight Index Rebalance: 12 Changes & US$4bn Round-Trip Trade

By Brian Freitas

  • There are 12 changes for the TIP Taiwan Technology Dividend Highlight Index in June/July. The Fuh Hwa Taiwan Technology Dividend Highlight ETF (00929 TW) has an AUM of US$7.16bn.
  • One-Way turnover is estimated at 35% and that will result in a round-trip trade of TWD 134.7bn (US$4.1bn). There are 8 stocks that could have over 5x ADV to trade.
  • The ETF started rebalancing their portfolio on Friday and will continue to trade the stock over the next 7 trading days.


(Mostly) Asia M&A, June 2024: Fancl, Capitol Health, Infocom,Jeisys Medical, Nagatanien, Henlius Bio

By David Blennerhassett

  • For the month of June 2024, 8 new transactions (firm and non-binding) were discussed on Smartkarma with an overall announced deal size of ~US$6bn.
  • The average premium for the new transactions announced (or first discussed) in June was ~52%. The average premium YTD is ~47%
  • This compares to the average premium for transactions in 2023 (117 transactions), 2022 (106), 2021 (165), 2020 (158), and 2019 (145 ) of 39%, 41%, 33%, 31%, and 31% respectively.

Potential Recurrence of Local Flow Trade Patterns in Hyundai Glovis’s Stock Dividend Event

By Sanghyun Park

  • Finding a trading entry point during a stock dividend event is tough, but locally, stock prices often rise post-ex-rights date and stabilize after listing, over 70% of the time.
  • There’s speculation that local flow trading, mainly driven by local prop traders, might target this pattern in Glovis’s stock dividend as well.
  • While I wouldn’t recommend banking on this probabilistic trading setup, it’s important to be aware that this could significantly impact stock movements from the ex-rights date to the listing date.

EQD / NSE Vol Update / IVs Rise in Conjunction with Equities Counter to Regular Spot-Vol Correlation

By Sankalp Singh

  • Implied Volatilities (IVs) continued to rise as the underlying index tried to break above critical resistance – marking a break-down of usual spot-vol correlations.
  • Vol surface smile & skew characteristics held steady at the 25-Delta point of curve, while dynamics at the 10-Delta zone extended further.
  • Nifty50 Back-end Term Structure is in Backwardation as Monthly options enjoy markups based on July-end Indian Budget release.   

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: Union Budget 2024- What to Expect? and more

By | Daily Briefs, Macro

In today’s briefing:

  • Union Budget 2024- What to Expect?
  • PBoC Examines Overhaul of Monetary Policy Framework, but Quantitative Easing Appears Unlikely
  • How Much Is Left in the Bulls’ Gas Tank?
  • Q2 Earnings Season Preview


Union Budget 2024- What to Expect?

By Nitin Mangal

  • All eyes will be on the upcoming Union Budget 2024 in July, marking the first of Modi Government 3.0.
  • Job creation, tackling agriculture woes including farmers income and sustaining expenditure on infra are expected to be the core deliverables.
  • Moreover, fiscal deficit is expected to continue its improvement run. Capital gains tax would not be touched but GST network could broaden.

PBoC Examines Overhaul of Monetary Policy Framework, but Quantitative Easing Appears Unlikely

By Said Desaque

  • The People’s Bank of China (PBoC) is studying the efficacy of buying and selling government bonds in the secondary market for liquidity management as opposed to introducing quantitative easing (QE).
  • China’s government bond market has increased significantly in size since 2008, but the PBoC has not, unlike the Fed, bought sovereign debt in over two decades.
  • Monetary policy conduct could be streamlined as the number of policy benchmark lending rates is reduced. Hopes of aggressive QE by the PBoC are far-fetched given its balance sheet structure.

How Much Is Left in the Bulls’ Gas Tank?

By Cam Hui

  • The stock market advance in 2024 has been impressive, but prices can continue to rise.
  • Market internals have become frothy and overbought in the AI-related leadership, but the rest of the market is showing signs of recovery that’s indicative of a leadership rotation.
  • Our base-case scenario calls for some near-term choppiness, followed by further gains into year-end.

Q2 Earnings Season Preview

By Cam Hui

  • Investors are facing a number of challenges as they approach Q2 earnings season. 
  • Bottom-Up EPS estimate revisions are strong, top-down economic releases have been weak. As well, forward P/E valuations are elevated
  • We interpret these conditions as the characteristics of a mid-cycle expansion.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Telix Pharmaceuticals, Actinogen Medical and more

By | Australia, Daily Briefs

In today’s briefing:

  • Quiddity Leaderboard ASX Sep 24 Rebal: Altium to Trigger Two Intra-Review Replacements in July
  • Actinogen Medical – Publication of XanADu biomarker analysis


Quiddity Leaderboard ASX Sep 24 Rebal: Altium to Trigger Two Intra-Review Replacements in July

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the potential index changes for ASX 200, 100, 50, and 20 in the run-up to the September 2024 index rebal event.
  • In July 2024, a couple of important Australian M&A deals could close and one of them could trigger intra-review additions for ASX 100 and ASX 200.
  • Separately, we see one ASX 100 change and one ASX 200 change during the September 2024 rebalance. For ASX 300, there could be 13 ADDs and 6 DELs.

Actinogen Medical – Publication of XanADu biomarker analysis

By Edison Investment Research

Actinogen Medical announced that the prespecified biomarker subset analyses on stored plasma samples (n=72) from its previous Phase IIa XanADu study (n=185) in patients with mild Alzheimer’s disease (AD) has been published in the peer-reviewed Journal of Alzheimer’s Disease (JAD). As reported in Q422, patients with elevated baseline phosphorylated Tau-181 (pTau-181) protein (at least 6.74pg/mL), representing 34 patients (16 on Xanamem 10mg daily, 18 on placebo), showed a 0.6 mean difference (effect size) on the CDR-SB scale at 12 weeks between the placebo and treatment arms, representing a 60% relative reduction in progression. This suggests that Xanamem’s potential cognitive or disease-slowing effects may be sensitively detected by the CDR-SB endpoint, which is one of the critical endpoints in the ongoing XanaMIA Phase IIb trial (planned n=220) enrolling participants with cognitive impairment (CI) in mild to moderate AD as confirmed through elevated baseline p-Tau181. Actinogen’s next milestone will be results, expected in early Q3 CY24, from its Phase IIa XanaCIDD study of Xanamem in patients with CI and major depressive disorder.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Lunit , Sanil Electric, SK Bioscience and more

By | Daily Briefs, South Korea

In today’s briefing:

  • End of Mandatory Lock-Up Periods for 55 Companies in Korea in July 2024
  • Sanil Electric IPO: The Bull Case
  • SK Bioscience (302440 KS): Acquiring Majority Stake in IDT Biologika- A Step Toward ‘Globalization’


End of Mandatory Lock-Up Periods for 55 Companies in Korea in July 2024

By Douglas Kim

  • We discuss the end of the mandatory lock-up periods for 55 stocks in Korea in July 2024, among which 6 are in KOSPI and 49 are in KOSDAQ.
  • These 55 stocks on average could be subject to further selling pressures in July and could underperform relative to the market.
  • The top three market cap stocks including those of which at least 1% of outstanding shares could be sold in July include Lunit, Mezzion Pharma, and DS Dansuk.

Sanil Electric IPO: The Bull Case

By Arun George

  • Sanil Electric (062040 KS), a Korean industrial transformer manufacturer, is seeking to raise up to US$165 million.    
  • The IPO is a pure primary raise of 7.6 million shares at an IPO price range of KRW24,000-30,000. Book building will run from 9 to 15 July.
  • The bull case rests on US-led rapid revenue growth, high barriers to entry, good revenue visibility, improving margins, top-quartile margin performance and modest leverage.

SK Bioscience (302440 KS): Acquiring Majority Stake in IDT Biologika- A Step Toward ‘Globalization’

By Tina Banerjee

  • SK Bioscience (302440 KS) secures 60% stake in IDT Biologika, a global CDMO company with state-of-the-art manufacturing facilities in Germany, for KRW339B ($244M). The valuation seems reasonable.
  • The transaction paves the way for SK bioscience to strengthen its global presence, notably in Europe and the U.S., and to diversify its business by expanding into bulk drug substances.
  • Based on the existing CDMO contracts, IDT Biologika’s outlook remains positive. SK bioscience aims to more than double its revenue and stabilize operating profit margins at 20%+.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: MoneyHero and more

By | Daily Briefs, Singapore

In today’s briefing:

  • MoneyHero – Encouraging start to FY24


MoneyHero – Encouraging start to FY24

By Edison Investment Research

MoneyHero has made a promising start to FY24, with robust levels of revenue growth in Q124 across several core markets and all product verticals. Investment in the platform has resulted in improved application conversion rates, while several senior hires have been made, including the new CFO, Hao Qian, and a head of AI. Although the EBITDA loss widened in the quarter, management expects profitability to improve to a break-even run rate by end FY24. Our estimates are unchanged, anticipating sequential quarterly revenue growth as management accelerates investment in its user base and benefits from operational leverage.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Indonesia: PT Metrodata Electronics and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • PT Metrodata Electronics (MTDL IJ) – A Future in AI Implementation


PT Metrodata Electronics (MTDL IJ) – A Future in AI Implementation

By Angus Mackintosh

  • PT Metrodata Electronics (MTDL IJ) saw a strong rebound in 1Q2024 for its distribution business, especially for telco products, which partially offset the slower growth in solutions & consulting. 
  • Solutions&consulting saw slow growth due to some delays over projects due to political uncertainty ahead of the election but it did have the support of recurrent income from software.
  • PT Metrodata Electronics should see a recovery in solutions & consulting in 2H2024, with increasing demand from AI-related projects, which will further drive future growth. Valuations remain attractive.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Occidental Petroleum, Copper, Fastly Inc, Papa John’S Intl, Cava Group , Visteon Corp, Costar Group, Group 1 Automotive, Commercial Metals Co, Ollie’S Bargain Outlet Holdings and more

By | Daily Briefs, United States

In today’s briefing:

  • Occidental Petroleum Corp (OXY) – Friday, Mar 29, 2024
  • Copper Tracker June 2024: Physical/Equity Screens And Trades For July
  • Fastly Inc.: How Is The Management Carrying Out The Expansion into New Market Segments?
  • Papa John’s International: Is The Focus on Aggregator and Digital Channels Paying Off? – Major Drivers
  • CAVA Group Inc.
  • Visteon Corporation: How Are They Carrying Out The Market Expansion in China? – Major Drivers
  • Costar Group Inc (CSGP) – Friday, Mar 29, 2024
  • Group 1 Automotive Inc.: A Story Of Strategic Acquisitions & Global Market Expansion! – Major Drivers
  • Commercial Metals Company: Will The Expansion and Optimization of Production Facilities Result In A Higher Top-Line? – Major Drivers
  • Ollie’s Bargain Outlet Holdings: How Is The Management Carrying Out Gross Margin Improvement through Supply Chain Optimization? – Major Drivers


Occidental Petroleum Corp (OXY) – Friday, Mar 29, 2024

By Value Investors Club

  • Occidental Petroleum is a quality oil and gas operator focusing on the Permian Basin, available at a discounted price for investors
  • The company has undergone strategic changes, selling off non-core operations and refocusing on core assets in the Permian Basin
  • Occidental Petroleum has improved management and technological advancements in the Permian Basin, leading to a projected value of $100 per share by 2026

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Copper Tracker June 2024: Physical/Equity Screens And Trades For July

By Sameer Taneja


Fastly Inc.: How Is The Management Carrying Out The Expansion into New Market Segments?

By Baptista Research

  • Fastly’s first quarter 2024 results demonstrate both promising advancements and headwinds that underscore the complexity of its market environment.
  • Revenue growth of 14% year-over-year to $133.5 million surpassed the midpoint of Fastly’s guidance, reflecting effective customer growth and retention initiatives.
  • The customer base expanded to 3,290, marking an increase from previous quarters.

Papa John’s International: Is The Focus on Aggregator and Digital Channels Paying Off? – Major Drivers

By Baptista Research

  • Papa John’s International, Inc. recently reported a mixed first quarter of 2024, demonstrating resilience in some areas of its operations while facing pressures in others.
  • The company has introduced a series of initiatives under its “Back to Better 2.0” strategy aimed at revitalizing the brand and enhancing profitability, yet it is still navigating through several challenges.
  • On the positive side, Papa John’s has launched several strategic measures to improve its marketing effectiveness and brand visibility.

CAVA Group Inc.

By Baptista Research

  • CAVA’s first quarter of 2024 financial results depict a mixed yet optimistic scenario for the Mediterranean cuisine leader.
  • The company reported solid revenue growth of 30.3% year-over-year reaching $256.3 million and a notable addition of 14 new restaurants, indicating aggressive expansion strategies into both existing and new markets.
  • The same-restaurant sales experienced a moderate increase of 2.3% or 30.7% on a 2-year basis which, while positive, might suggest a deceleration in same-restaurant sales growth momentum when compared to historical data.

Visteon Corporation: How Are They Carrying Out The Market Expansion in China? – Major Drivers

By Baptista Research

  • Visteon Corporation demonstrated robust performance in the first quarter of 2024, navigating a challenging and varied market environment with strategic finesse.
  • The company reported a solid kickoff to the year with $933 million in sales, attributed to heightened demand for its Digital Clusters and cockpit domain controllers, which both saw a 20% year-over-year increase.
  • The noteworthy expansion in Battery Management Systems (BMS) sales, which more than doubled compared to the prior year, was another highlight, significantly contributing to a positive growth-over-market rate at 2%.

Costar Group Inc (CSGP) – Friday, Mar 29, 2024

By Value Investors Club

  • NAR settlement presents big opportunity for CSGP’s homes.com business with rapid growth in traffic and monetization
  • CSGP trading in-line with historical valuation, offering a cheap option on homes.com network for further growth
  • Settlement may lead to unbundling of buy-side commissions, disrupting traditional US portal model and driving CSGP stock higher

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Group 1 Automotive Inc.: A Story Of Strategic Acquisitions & Global Market Expansion! – Major Drivers

By Baptista Research

  • Group 1 Automotive recently held a comprehensive review of its first quarter 2024 financial results, reflecting significant developments and strategic advancements.
  • Notable was the acquisition of Inchcape Retail, a move positioned as the largest dealership transaction in the company’s history, signaling Group 1 Automotive’s strategic growth through mergers and acquisitions (M&A).
  • This acquisition was highlighted as immediately accretive, enhancing the company’s footprint in both new and existing markets without necessitating substantial facility investment, further emphasizing prudent capital allocation.

Commercial Metals Company: Will The Expansion and Optimization of Production Facilities Result In A Higher Top-Line? – Major Drivers

By Baptista Research

  • Commercial Metals Company (CMC) recently shared the outcomes of its third quarter fiscal 2024 results, presenting a resilient financial and operational performance amidst the complexities of the steel industry and broader market uncertainties.
  • On the positive side, CMC reported strong core EBITDA and margin results, with performance levels well above the company’s historic averages.
  • The earnings resilience can be attributed to positive shifts in the company’s business structure and the steel industry, notably marked by CMC’s strategic acquisitions that have bolstered its market leadership and enhanced the operational efficiency of its asset base.

Ollie’s Bargain Outlet Holdings: How Is The Management Carrying Out Gross Margin Improvement through Supply Chain Optimization? – Major Drivers

By Baptista Research

  • Ollie’s Bargain Outlet recently discussed its financial results for the first quarter of fiscal year 2024, presenting a detailed analysis of its operational performance and outlook.
  • During the presentation, the company highlighted several positives including a notable 49% increase in adjusted earnings per share, underpinned by better-than expected performances in comparable store sales, total revenue, gross margin, and expenses.
  • This robust performance underscores the company’s effective execution despite the ongoing economic pressures influencing consumer spending.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Latent View Analytics Ltd, Asian Paints and more

By | Daily Briefs, India

In today’s briefing:

  • The Beat Ideas- Latent View Analytics: Harnessing Data & Analytics
  • India Channel Insight | Asian Paints (APNT IN) | Mindshare Master


The Beat Ideas- Latent View Analytics: Harnessing Data & Analytics

By Sudarshan Bhandari

  • Client-Driven innovation fosters R&D via proactive, marketable solutions and an SDE framework for excellence
  • In-Depth understanding of sectors and data-driven innovation drives strategic growth
  • Comprehensive data analytics solutions from start to finish for business success

India Channel Insight | Asian Paints (APNT IN) | Mindshare Master

By Pranav Bhavsar

  • We visited some paint dealers representing Asian Paints (APNT IN) and Akzo Nobel India (AKZO IN)  to understand the current competitive intensity in the industry.
  • While three months is too short of a time frame to observe a significant change in industry structure, current signals seem to favor the incumbent. 
  • Opus may influence dealers and painters, but what if consumers simply prefer APNT?

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Keisei Electric Railway Co and more

By | Daily Briefs, Japan

In today’s briefing:

  • Last Week in Event SPACE: Keisei Electric, China Merchants, Great Eastern, Jardine Matheson/JCNC


Last Week in Event SPACE: Keisei Electric, China Merchants, Great Eastern, Jardine Matheson/JCNC

By David Blennerhassett

  • No surprise: Keisei Electric Railway (9009 JP) shareholders voted down Palliser’s proposal. If the vote was close, Palliser may ups its rhetorical game, and takes a harder stance.
  • Argyle failed to boot one CMCDI (133 HK) director. They’ll next target the management agreement renewal; and agitate the company buy back 20% of shares outstanding at 90% of NAV.
  • The Offeror now has 90.16% in Great Eastern Holdings (GE SP) – so this will get suspended at the close of the Offer.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars